Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Seagen Inc (SGEN)

NASDAQ
Currency in USD
Disclaimer
228.74
0.00(0.00%)
Closed

SGEN Comments

its an arbitrage opportunity
what happened?
azeem Malik
The European Commission (EC) has granted marketing authorization for Seagen's (NASDAQ:SGEN) Tukysa (tucatinib) in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least two prior anti-HER2 treatment regimens.
What is the news?
Apprently they may be included in the S&P 500, and hence funds. Just like Tesla a few weeks back
 Did you hold a position?
Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
Price drop is the result of the #1 Institutional holder (Baker Bros) selling the entire position.
Executing through a secondary offering. The company issued a press release on it.
Charles Coolidge, prove it.
Charles Coolidge, prove it.
Seagen (SGEN) Gets Positive CHMP Opinion for Breast Cancer Drug  December 14, 2020
180+
Buy buy buy
Reports tomorrow worth a BUY? > www.tradeticker.news/sgen/
Phase 2 data of Tisotumab vedotin would be something to watch for !!! Eventual approval by FDA is anticipated
It’s a great buy at $149.. Target $185
Did you hold a position?
buy?
Lots of pratying an thing the Lord an praising Him.an Represents of sin believe an truest in the Lord Jesus Christ an Father an the Holy spirit
Think you all very much you don't a great job .be bless if it God will
Powerful teaming up with Merck on cancer drug!
i dont care sbout the stock but i am thankful for their work.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.